Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEHR TEST SYSTEMSAEHR · Entity 2640 | Director · President and CEO | October 12, 2026 | October 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEHR TEST SYSTEMS
Report date October 12, 2026 · Filed October 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 191,108 |
Reported balance
After 2026-10-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-12 · Tax withholding · Disposed 2,675 · Balance 191,108 F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 158,776 |
Reported balance
Holding disclosure · report date 2026-10-12 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 158,776 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person.
F2: The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 07, 2017 Filed Aug 8, 2017 22:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 17,300 | $3.71 | $64,234.90 |
DisclosureSEC source: 0001040470-17-000055 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,763 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 22:04 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $3.82 | $76,420.00 |
DisclosureSEC source: 0001040470-17-000055 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 318,063 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 22:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 10,344 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001040470-17-000041 · primary_doc.xml · derivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,344 Underlying: Common Stock · 10,344 shares Expires 2024-07-11 F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 22:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantIncentive Stock Option (right to buy) · Derivative | 23,856 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001040470-17-000041 · primary_doc.xml · derivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,856 Underlying: Common Stock · 23,856 shares Expires 2024-07-11 F2 · derivative.exercise_date: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter. Read SEC document |
| July 11, 2017 Filed Jul 13, 2017 22:00 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 11,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-17-000041 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,063 F1 · shares: One-sixteenth (1/16) of the total number of shares subject to the restricted stock unit awards shall become exercisable at the end of each three full calendar months following the date of this action, provided that such recipient is still employed by the corporation on such dates. Read SEC document |
| April 03, 2017 Filed Apr 5, 2017 00:39 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $0.99 | $2,958.00 |
DisclosureSEC source: 0001040470-17-000028 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,663 F1 · shares: These shares have been purchased through the Company's 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
| February 21, 2017 Filed Feb 28, 2017 23:24 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | Tax withholdingCommon Stock | 14,031 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-17-000021 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 323,663 Read SEC document |
| February 21, 2017 Filed Feb 28, 2017 23:24 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | GrantCommon Stock | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001040470-17-000021 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,694 F1 · shares: Represents shares of common stock issued upon vesting of performance based RSUs. Read SEC document |
| February 08, 2017 Filed Feb 9, 2017 00:37 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 20,000 | $3.29 | $65,776.00 |
DisclosureSEC source: 0001040470-17-000016 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 302,694 F1 · security: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2016. Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 300 | $2.98 | $894.00 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 8 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,694 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,600 | $2.97 | $4,752.00 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 7 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 322,994 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,100 | $2.96 | $6,216.00 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 6 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 324,594 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,920 | $2.91 | $8,497.20 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 5 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,694 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,080 | $2.90 | $8,932.00 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 4 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,614 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 1,975 | $2.89 | $5,707.75 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 332,694 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,800 | $2.88 | $10,944.00 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,669 Read SEC document |
| October 10, 2016 Filed Oct 11, 2016 22:22 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 4,225 | $2.86 | $12,083.50 |
DisclosureSEC source: 0001040470-16-000130 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,469 Read SEC document |
| October 07, 2016 Filed Oct 7, 2016 21:53 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 3,000 | $2.70 | $8,100.00 |
DisclosureSEC source: 0001040470-16-000127 · primary_doc.xml · nonDerivative · entry 3 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 342,694 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 21:53 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 2,000 | $2.85 | $5,700.00 |
DisclosureSEC source: 0001040470-16-000127 · primary_doc.xml · nonDerivative · entry 2 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,694 Read SEC document |
| October 06, 2016 Filed Oct 7, 2016 21:53 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | SaleCommon Stock | 5,000 | $2.87 | $14,350.00 |
DisclosureSEC source: 0001040470-16-000127 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,694 Read SEC document |
| October 03, 2016 Filed Oct 4, 2016 18:53 UTC | AEHR TEST SYSTEMS AEHR · Entity 2640 | OtherCommon Stock | 3,000 | $0.99 | $2,958.00 |
DisclosureSEC source: 0001040470-16-000124 · primary_doc.xml · nonDerivative · entry 1 Erickson Gayn · CIK 0001364097 · Director · President & C.E.O 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 352,694 F1 · shares: These shares have been purchased through the Company's 2006 Employee Stock Purchase Plan, a "tax-conditioned plan" per Internal Revenue Code Section 423. This purchase is exempt from Section 16 of the Securities Exchange Act of 1934 regarding liabilities arising from six-month short-swing transactions in the Company's securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.